AbbVie Launches Phase I Clinical Trial for ABBV-1882, Promising HIV Drugs Treatment Approach

The initiation of the phase I clinical trial for ABBV-1882 marks a significant milestone in the quest for novel HIV treatments. With its unique mechanism of action and potential to transform HIV management, ABBV-1882 represents a beacon of hope for individuals living with HIV and underscores AbbVie's unwavering commitment to advancing science for the benefit of patients worldwide.

Don't Miss: Huateng Pharma's Exhibit at CPHI Japan 2024

Hunan Huateng Pharmaceutical Co., Ltd is set to present its groundbreaking solutions at CPHI Japan 2024, showcasing expertise in PEG derivatives and CDMO services. Attendees are encouraged to visit Booth No. 4X-08 to explore cutting-edge offerings and engage with industry experts.

Join Biopharma PEG Scientific Inc. at PEGS Boston Summit and TIDES USA 2024

Biopharma PEG Scientific Inc. will showcase its latest high-purity polyethylene glycol (PEG) derivatives and custom synthesis solutions at Booth No. 718 in PEGS Boston Summit 2024 and at TIDES USA 2024 at Booth No. 935.

CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies

New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year

New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day

Bioforum Expands Leadership Team with Appointment of Michael Goedde as President

Life Sciences Industry Veteran to Lead Development and Execution of Growth and Innovation Strategy, Expanding Global Reach of Bioforum’s Biometric Services and Solutions

Quotient Sciences Strengthens Its Top Team with Three New Appointments

SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient

New Paper from Insilico Medicine Demonstrates Validity of AI Drug Discovery

Now, for the first time, a new paper in Nature Biotechnology from clinical stage AI-driven biotechnology company Insilico Medicine reveals the entire process behind the company’s lead AI-designed molecule for an AI-discovered target for the chronic, progressive and often fatal rare lung disease idiopathic pulmonary fibrosis (IPF), which impacts 5 million people worldwide.

Veramed appoints Karen Curran as Chief Strategy Officer

Specialist Biometrics CRO, Veramed has announced the appointment of Karen Curran as Chief Strategy Officer.

New AvalonSelect Genetic Network Offers Health Plans Control, Quality, and Savings in Genetic Testing

New AvalonSelect Genetic Network Offers Health Plans Control, Quality, and Savings in Genetic Testing

Darling Ingredients’ Health Brand Rousselot Announces Online Access to Research- and Technical-Grade X-Pure Gelatins through BIO INX

Darling Ingredients’ health brand Rousselot, a global leader in gelatin- and collagen-based solutions, announced today that its high-quality, research- and technical-grade gelatins are now available for online purchase in Canada, Europe, South Korea and the U.S. through BIO INX, a pioneering developer and distributor of materials for 3D bioprinting.

Clearwater Introduces IRM|Performance to Power Cybersecurity Maturity and Resiliency

FDB Adds CDS Hooks Specification to Its Targeted Medication Warnings™ Solution

Streamlined integration makes it easier for more IT developers to present trusted, patient-specific medication decision support from FDB

Linus Health Acquires Aural Analytics

Linus Health Acquires Aural Analytics - Purchase Expands Linus Health’s Cognitive Assessment Capabilities

HIMSS24: Linus Health Unveils Two New Evidence-Based, Digital Cognitive Screening Additions to its Comprehensive Brain Health Platform

HIMSS24: Linus Health Unveils Two New Evidence-Based, Digital Cognitive Screening Additions to its Comprehensive Brain Health Platform

Oxford Nanopore launches PromethION 2 Integrated into open early access

Oxford Nanopore Technologies announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated (P2i).

Amerigo Scientific Releases Cyclic-di-GMP Assay to Simplify Cellular Function Analysis

Hovione partners with Dragonfly Technologies to offer micellar chemistry technology to customers as a sustainable alternative to conventional chemical processes

Phastar Vice President Prof Jennifer Visser-Rogers Named in Women in Data® Twenty in Data & Technology

Phastar Vice President Prof Jennifer Visser-Rogers Named in Women in Data® Twenty in Data & Technology Prof Visser-Rogers chosen for showcase of inspirational, trailblazing and dedicated women in data and tech.